SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
1352458508096868v1
15/1/116    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sutton, I
Right arrow Articles by Barnett, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutton, I
Right arrow Articles by Barnett, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

CNS demyelination and quadrivalent HPV vaccination

I Sutton1, R Lahoria2, IL Tan3, P Clouston4, and MH Barnett5*

1 Department of Neurology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia; The Brain and Mind Research Institute, The University of Sydney, New South Wales, Australia
2 St George Hospital, Kogarah, New South Wales, Australia
3 Department of Neurology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia
4 Westmead Hospital, Westmead, New South Wales, Australia
5 The Brain and Mind Research Institute, The University of Sydney, New South Wales, Australia; St George Hospital, Kogarah, New South Wales, Australia

* To whom correspondence should be addressed.


  Abstract

Vaccination is generally considered safe in patients with multiple sclerosis (MS). We report five patients who presented with multifocal or atypical demyelinating syndromes within 21 days of immunization with the quadrivalent human papilloma virus (HPV) vaccine, Gardasil®. Although the target population for vaccination, young females, has an inherently high risk for MS, the temporal association with demyelinating events in these cases may be explained by the potent immuno-stimulatory properties of HPV virus-like particles which comprise the vaccine. A prospective case–control study of patients with MS or clinically isolated demyelinating syndromes receiving the Gardasil® vaccine may provide relevant safety data in this population.

Key Words: demyelination, multiple sclerosis, human papillomavirus, vaccination

First published on September 19, 2008, doi:10.1177/1352458508096868

Multiple Sclerosis 2009;15:116.

A more recent version of this article appeared on January 1, 2009

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Pediatr. Rev.Home page
E. M. Moore and S. B. Johnson
Research and Statistics: Case Reports, Anecdotal Evidence, and Descriptive Epidemiologic Studies in Pediatric Practice
Pediatr. Rev., August 1, 2009; 30(8): 323 - 324.
[Full Text] [PDF]

Home page
 NeurologyHome page
B. Wildemann, S. Jarius, M. Hartmann, J. U. Regula, and C. Hametner
ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING VACCINATION AGAINST HUMAN PAPILLOMA VIRUS
Neurology, June 16, 2009; 72(24): 2132 - 2133.
[Full Text] [PDF]


Advertisement